733 results on '"Kouyos, Roger D"'
Search Results
2. Assessing immunogenicity barriers of the HIV-1 envelope trimer
3. Antibiotic prophylaxis before dental procedures to prevent infective endocarditis: a systematic review
4. HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis
5. Identifying Contact Risks for SARS-CoV-2 Transmission to Healthcare Workers during Outbreak on COVID-19 Ward
6. Recommendations on data sharing in HIV drug resistance research
7. Assessing the role of bacterial innate and adaptive immunity as barriers to conjugative plasmids
8. Modifiable and nonmodifiable risk factors for non-ventilator-associated hospital-acquired pneumonia identified in a retrospective cohort study
9. Quantification of transgene expression in GSH AAVS1 with a novel CRISPR/Cas9-based approach reveals high transcriptional variation
10. Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: Systematic review and Bayesian evidence synthesis
11. The impact of public health interventions on the future prevalence of ESBL-producing Klebsiella pneumoniae: a population based mathematical modelling study
12. Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screen.
13. Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+decline
14. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
15. Cohort Profile: The Zurich Primary HIV Infection Study
16. The effect of combining antibiotics on resistance: A systematic review and meta-analysis
17. Author Response: The effect of combining antibiotics on resistance: A systematic review and meta-analysis
18. Quantifying the impact of treatment history on plasmid-mediated resistance evolution in human gut microbiota
19. Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics
20. Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral Therapy.
21. Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study.
22. Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization
23. Correction to: Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study
24. Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study
25. Author Correction: Efficient microbial colony growth dynamics quantification with ColTapp, an automated image analysis application
26. Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity
27. Impact of an electronic alert on prescription patterns of meropenem, voriconazole and caspofungin
28. The path of least resistance: aggressive or moderate treatment?
29. Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
30. Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?
31. Incidence of sexually transmitted infections and association with behavioural factors: Time‐to‐event analysis of a large pre‐exposure prophylaxis (PrEP) cohort.
32. Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applications
33. No Effect of Pegylated Interferon-α on Total HIV-1 DNA Load in HIV-1/HCV Coinfected Patients
34. High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 Infection
35. Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for the presence of persisters across clinical presentations
36. Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
37. Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment
38. Efficient microbial colony growth dynamics quantification with ColTapp, an automated image analysis application
39. Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial
40. Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
41. Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study
42. Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years
43. Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland.
44. Seroprofiling of antibodies against endemic human coronaviruses and SARS-CoV-2 in an HIV cohort in Lesotho: correlates of antibody response and seropositivity
45. Migrating a Well-Established Longitudinal Cohort Database From Oracle SQL to Research Electronic Data Entry (REDCap): Data Management Research and Design Study
46. Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1
47. Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis
48. Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study
49. Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis
50. HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.